Other carcinoid syndrome
ICD-10 E34.09 is a billable code used to indicate a diagnosis of other carcinoid syndrome.
Carcinoid syndrome is a group of symptoms that occur in patients with carcinoid tumors, which are neuroendocrine tumors that typically arise in the gastrointestinal tract or lungs. These tumors can secrete various hormones, including serotonin, which leads to a range of clinical manifestations. Symptoms of carcinoid syndrome may include flushing, diarrhea, wheezing, and abdominal pain. In some cases, the syndrome can lead to significant hormonal imbalances, affecting growth and development, particularly in children and adolescents. This can result in puberty disorders, such as delayed or precocious puberty, and growth abnormalities due to the excess secretion of hormones. Additionally, carcinoid syndrome can be associated with polyglandular dysfunction, where multiple endocrine glands are affected, leading to further complications. Thymus disorders may also be observed in patients with carcinoid tumors, as the thymus plays a role in the immune response and can be influenced by neuroendocrine activity. Accurate diagnosis and management of carcinoid syndrome require a multidisciplinary approach, including endocrinology, oncology, and gastroenterology.
Detailed hormonal assay results, growth charts, and puberty assessment.
Patients presenting with growth abnormalities or delayed puberty.
Ensure comprehensive documentation of endocrine evaluations and any associated disorders.
Pathology reports, imaging studies, and treatment plans.
Management of carcinoid tumors and associated syndromes.
Document tumor location, size, and any metastasis for accurate coding.
Used when a biopsy of a suspected carcinoid tumor is performed.
Pathology report detailing tumor characteristics.
Ensure the pathology report is linked to the correct diagnosis.
Common symptoms include flushing, diarrhea, wheezing, and abdominal pain, which can vary based on the tumor's location and hormone secretion.
